Lifecare Pcainfusion Firmware
Monthly
Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP packets. Rated high severity (CVSS 7.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.
Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors. Rated medium severity (CVSS 4.6), this vulnerability is low attack complexity. No vendor patch available.
Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to execute arbitrary code via unspecified vectors. Rated critical severity (CVSS 10.0), this vulnerability is remotely exploitable, low attack complexity. Epss exploitation probability 14.4% and no vendor patch available.
Hospira LifeCare PCA Infusion System before 7.0 has hardcoded credentials, which makes it easier for remote attackers to obtain access via unspecified vectors. Rated medium severity (CVSS 5.0), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.
The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote. Rated high severity (CVSS 7.6), this vulnerability is remotely exploitable. No vendor patch available.
The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for root TELNET sessions, which allows remote attackers to modify the pump. Rated critical severity (CVSS 10.0), this vulnerability is remotely exploitable, low attack complexity. Epss exploitation probability 17.7% and no vendor patch available.
Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP packets. Rated high severity (CVSS 7.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.
Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors. Rated medium severity (CVSS 4.6), this vulnerability is low attack complexity. No vendor patch available.
Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to execute arbitrary code via unspecified vectors. Rated critical severity (CVSS 10.0), this vulnerability is remotely exploitable, low attack complexity. Epss exploitation probability 14.4% and no vendor patch available.
Hospira LifeCare PCA Infusion System before 7.0 has hardcoded credentials, which makes it easier for remote attackers to obtain access via unspecified vectors. Rated medium severity (CVSS 5.0), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.
The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote. Rated high severity (CVSS 7.6), this vulnerability is remotely exploitable. No vendor patch available.
The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for root TELNET sessions, which allows remote attackers to modify the pump. Rated critical severity (CVSS 10.0), this vulnerability is remotely exploitable, low attack complexity. Epss exploitation probability 17.7% and no vendor patch available.